Protocol of the Swiss Longitudinal Cohort Study (SWICOS) in rural Switzerland

Introduction Increased longevity and consequent major changes in demographics and population lifestyles necessitate new approaches to reduce the burden of ageing-related diseases (including cardiovascular disease) and maintain an optimal quality of life. This study aims to examine and longitudinally follow health status and disease risk factors in a Swiss rural cohort, evaluating all health-related research and practice disciplines to assure development of new implementable and successful preventive strategies for healthy ageing. Methods and objectives Small Swiss villages with low migration rates will be selected for this study. 2 villages (Cama/Lostallo) have already been selected as initial study sites. All residents (age ≥6 years, no upper age limit) are eligible. The target enrolment number per village is 300. Examinations and measurements encompass medical history, anthropometry, cardiac and vascular health, pulmonary function, physical performance, nutritional, mental and emotional status, biochemical and molecular analyses. Follow-up examinations (identical to baseline) will be performed after 5 and 10 years, and in 10-year intervals thereafter. The major objective is to assess, and observe change in, health status over time in a prospective manner. Secondary objectives are to: (1) identify ‘hidden’ (asymptomatic and/or unrecognised) health problems which enhance risk for chronic diseases; (2) identify barriers to accessing healthcare and adapting health behaviours; (3) evaluate efficacy of present preventive strategies and recommendations; (4) evaluate knowledge and attitude towards ongoing health programmes and public health recommendations; (5) monitor change and progress towards the national health objectives; (6) formulate new preventive strategies and recommendations based on the findings and knowledge base of the past 10 years; (7) formulate models for successful prevention of chronic diseases and for healthy ageing. Ethics and dissemination The Ethics Committee of Nordwest-und Zentralschweiz approved this study (EKNZ 2014-209). It is registered at ClinicalTrials.gov (NCT02282748). Findings will be disseminated through scientific articles/presentations and public events.

[1]  M. Burnier,et al.  Salt, blood pressure and cardiovascular risk: what is the most adequate preventive strategy? A Swiss perspective , 2015, Front. Physiol..

[2]  P. Palatini,et al.  Validation of the Thermor BIOS BD215 device for home blood pressure measurement according to the European Society of Hypertension International Protocol revision 2010 , 2014, Blood pressure monitoring.

[3]  G. Parati,et al.  Ischemic changes in exercise ECG in a hypertensive subject acutely exposed to high altitude. Possible role of a high-altitude induced imbalance in myocardial oxygen supply-demand. , 2014, International journal of cardiology.

[4]  R. Asmar,et al.  Validation of four devices: Omron M6 Comfort, Omron HEM-7420, Withings BP-800, and Polygreen KP-7670 for home blood pressure measurement according to the European Society of Hypertension International Protocol , 2014, Vascular health and risk management.

[5]  Ralph L. Sacco,et al.  American Heart Association Guide for Improving Cardiovascular Health at the Community Level, 2013 Update: A Scientific Statement for Public Health Practitioners, Healthcare Providers, and Health Policy Makers , 2013, Circulation.

[6]  M. Bochud,et al.  1999–2009 Trends in Prevalence, Unawareness, Treatment and Control of Hypertension in Geneva, Switzerland , 2012, PloS one.

[7]  H. So,et al.  Validation of A&D TM-2430 upper-arm blood pressure monitor for ambulatory blood pressure monitoring in children and adolescents, according to the British Hypertension Society protocol , 2012, Blood pressure monitoring.

[8]  K. Flegal,et al.  Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010. , 2012, JAMA.

[9]  M. Decramer,et al.  Accuracy of Office Spirometry Performed by Trained Primary-Care Physicians Using the MIR Spirobank Hand-Held Spirometer , 2012, Respiration.

[10]  S. Iijima [The Baltimore Longitudinal Study of Aging (BLSA)]. , 2011, Nihon rinsho. Japanese journal of clinical medicine.

[11]  B. Gaszner,et al.  Invasive validation of a new oscillometric device (Arteriograph) for measuring augmentation index, central blood pressure and aortic pulse wave velocity , 2010, Journal of hypertension.

[12]  B. Löwe,et al.  The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: a systematic review. , 2010, General hospital psychiatry.

[13]  R. Kobza,et al.  Recorded heart sounds for identification of ventricular tachycardia. , 2008, Resuscitation.

[14]  P. Erne,et al.  Beyond auscultation--acoustic cardiography in the diagnosis and assessment of cardiac disease. , 2008, Swiss medical weekly.

[15]  M. Pencina,et al.  General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study , 2008, Circulation.

[16]  Charles E McCulloch,et al.  Relaxing the rule of ten events per variable in logistic and Cox regression. , 2007, American journal of epidemiology.

[17]  N. Ruckstuhl,et al.  Obesity during growth in Switzerland: role of early socio-cultural factors favouring sedentary activities , 2006, International Journal of Obesity.

[18]  T Fahey,et al.  Accuracy and impact of risk assessment in the primary prevention of cardiovascular disease: a systematic review , 2006, Heart.

[19]  T. Tombaugh Trail Making Test A and B: normative data stratified by age and education. , 2004, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists.

[20]  James F Sallis,et al.  AHA Guidelines for Primary Prevention of Cardiovascular Disease and Stroke: 2002 Update: Consensus Panel Guide to Comprehensive Risk Reduction for Adult Patients Without Coronary or Other Atherosclerotic Vascular Diseases. American Heart Association Science Advisory and Coordinating Committee. , 2002, Circulation.

[21]  W. Beam,et al.  A 30-s chair-stand test as a measure of lower body strength in community-residing older adults. , 1999, Research quarterly for exercise and sport.

[22]  G. Assmann,et al.  The Münster Heart Study (PROCAM). Results of follow-up at 8 years. , 1998, European heart journal.

[23]  G. Assmann,et al.  The Münster Heart Study (PROCAM): total mortality in middle-aged men is increased at low total and LDL cholesterol concentrations in smokers but not in nonsmokers. , 1997, Circulation.

[24]  H. Krumholz,et al.  Guide to primary prevention of cardiovascular diseases. A statement for healthcare professionals from the Task Force on Risk Reduction. American Heart Association Science Advisory and Coordinating Committee. , 1997, Circulation.

[25]  R B D'Agostino,et al.  Changes in risk factors and the decline in mortality from cardiovascular disease. The Framingham Heart Study. , 1990, The New England journal of medicine.

[26]  Ivan Silver,et al.  The challenge of time: Clock‐drawing and cognitive function in the elderly , 1986 .

[27]  P. Henkind,et al.  Compendium of ophthalmology , 1983 .

[28]  D. Schoenfeld,et al.  Sample-size formula for the proportional-hazards regression model. , 1983, Biometrics.

[29]  HELEN B. HUBERT,et al.  Obesity as an Independent Risk Factor for Cardiovascular Disease: A 26‐year Follow‐up of Participants in the Framingham Heart Study , 1983, Circulation.

[30]  W. Kannel,et al.  An investigation of coronary heart disease in families. The Framingham offspring study. , 1979, American journal of epidemiology.

[31]  S. Folstein,et al.  “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician , 1975 .

[32]  M. Lawton,et al.  Assessment of older people: self-maintaining and instrumental activities of daily living. , 1969, The Gerontologist.

[33]  L. Widmer,et al.  Occlusion of Peripheral Arteries: A Study of 6,400 Working Subjects , 1964, Circulation.

[34]  S. Katz,et al.  STUDIES OF ILLNESS IN THE AGED. THE INDEX OF ADL: A STANDARDIZED MEASURE OF BIOLOGICAL AND PSYCHOSOCIAL FUNCTION. , 1963, JAMA.

[35]  C. de Pietro,et al.  Switzerland: Health System Review. , 2015, Health systems in transition.

[36]  D. Wade,et al.  Validity and reliability comparison of 4 mobility measures in patients presenting with neurologic impairment. , 2001, Archives of physical medicine and rehabilitation.

[37]  J. Crowther,et al.  A simple screening test for hearing impairment in elderly patients. , 1988, Age and ageing.